Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson’s disease

Serum homocysteine and dementia: Meta-analysis of eight cohort studies including 8669 participants

(2011) David S. Wald et al.   Alzheimers & Dementia

Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases

(2011) Paula Grammas et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study

(2011) B. Hooshmand et al.   JOURNAL OF INTERNAL MEDICINE

Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease

(2011) Paula Grammas   Journal of Neuroinflammation

Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia

(2011) Andrew H Ford et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cognitive impairment in nondemented Parkinson's disease

(2011) Paolo Barone et al.   MOVEMENT DISORDERS

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia

(2010) Walter J. Schulz-Schaeffer   ACTA NEUROPATHOLOGICA

TheSLC19A180G>A polymorphism is not associated with male infertility

(2010) Mateusz Kurzawski et al.   BIOMARKERS

Association of MTHFR, MTR, and MTRR polymorphisms with Parkinson's disease among ethnic Chinese in Taiwan

(2010) Chin-Shih Fong et al.   CLINICA CHIMICA ACTA

Homocysteine, Another Risk Factor for Alzheimer Disease, Impairs Apolipoprotein E3 Function

(2010) Hirohisa Minagawa et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson’s disease

(2010) Chiaki Isobe et al.   JOURNAL OF CLINICAL NEUROSCIENCE

The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population

(2010) P. Hobson et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease

(2010) Jeroen Hoogland et al.   MOVEMENT DISORDERS

Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to Alzheimer's disease

(2010) Min-Yue Zhang et al.   NEUROSCIENCE RESEARCH

The progression of pathology in Parkinson's disease

(2009) Glenda Margaret Halliday et al.   Annals of the New York Academy of Sciences

Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients

(2009) Rey-Yue Yuan et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study

(2009) Maria C. Rodriguez-Oroz et al.   MOVEMENT DISORDERS

Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels

(2008) Elizabeth M. Tunbridge et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients

(2008) Richard M. Camicioli et al.   MOVEMENT DISORDERS

Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy

(2008) Pekka Jokinen et al.   PARKINSONISM & RELATED DISORDERS

The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinsonʼs disease, levodopa treatment response, and complications

(2008) Monika Bialecka et al.   Pharmacogenetics and Genomics